CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.
Arcangeli S, Bove C, Mezzanotte C, Camisa B, Falcone L, Manfredi F, Bezzecchi E, El Khoury R, Norata R, Sanvito F, Ponzoni M, Greco B, Moresco MA, Carrabba MG, Ciceri F, Bonini C, Bondanza A, Casucci M.
Arcangeli S, et al. Among authors: bove c.
J Clin Invest. 2022 Jun 15;132(12):e150807. doi: 10.1172/JCI150807.
J Clin Invest. 2022.
PMID: 35503659
Free PMC article.